Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions Inc. (NASDAQ: TOMZ) delivers cutting-edge decontamination systems through its patented SteraMist technology. This news hub provides investors and industry professionals with essential updates about the company’s infection prevention solutions, strategic partnerships, and regulatory milestones.
Access real-time announcements including product launches, financial results, and technology licensing agreements. Our curated collection features press releases about BIT platform advancements, facility deployments across healthcare and government sectors, and compliance achievements.
Key updates cover global expansion efforts, research collaborations with defense organizations, and industry certifications validating SteraMist’s efficacy. Bookmark this page to monitor how TOMI addresses evolving disinfection challenges while maintaining operational excellence in critical environments.
TOMI Environmental Solutions (NASDAQ: TOMZ), a global decontamination and infection prevention company, has scheduled its Q2 2025 earnings conference call for August 14, 2025, at 4:30 p.m. ET. The company will release its financial results for the quarter ended June 30, 2025, after market close on the same day.
TOMI specializes in disinfection solutions through its proprietary Binary Ionization Technology® (BIT™) platform, which was developed under a DARPA defense grant. The technology uses ionized Hydrogen Peroxide (iHP™) and serves various sectors including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings.
TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, has secured its fourth order for the SteraMist Integration System (SIS) platform from ARES Distribution. The order, placed for a biomedical research university in Coral Gables, Florida, is scheduled for delivery in late 2025.
The company's proprietary Binary Ionization Technology® (BIT™), developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection. The technology serves various sectors including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings.
TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination solutions provider, has announced the successful first installation of its SteraMist Integration System – Standalone (SIS-SA) in the life sciences sector, specifically for the pharmaceutical isolator market. The installation was completed at a leading pharmaceutical CDMO that had previously invested in SteraMist technology.
The company expects to generate over $500,000 in revenue from the new SIS-SA product in fiscal 2025. With the life science sterility testing market projected to reach $3.4 billion by 2031 at a CAGR of 12.4%, TOMI is positioning itself to capitalize on the growing demand for sterile drug manufacturing environments through its innovative Binary Ionization Technology® (BIT™) platform.
TOMI Environmental Solutions (NASDAQ: TOMZ) reported its Q4 and full-year 2024 financial results, showing mixed performance. Annual revenue increased by 5% to $7.74 million, with international revenue growing 33%. However, the company faced significant challenges with GAAP net loss widening to $(4.48 million) or $(0.22) per share in 2024, compared to $(3.40 million) or $(0.17) per share in 2023.
Q4 2024 showed particular weakness with net sales declining to $1.07 million from $1.53 million in Q4 2023, and gross margin turning negative at -49.5%. However, preliminary Q1 2025 results indicate a strong rebound with revenue up 42% to $1.58 million and solution sales growing approximately 200% quarter-over-quarter. The company's sales backlog increased 40% to $1.23 million by March 2025.
TOMI Environmental Solutions (NASDAQ: TOMZ) has scheduled its Q4 2024 earnings conference call for April 14, 2025, at 4:30 p.m. ET, following the release of financial results after market close. The company specializes in disinfection and decontamination solutions through its proprietary Binary Ionization Technology (BIT) platform.
Investors can access the call by dialing (888) 506-0062 (US) or (973) 528-0011 (International) with access code 818389. A webcast replay will be available for 90 days, and telephone replay until April 28, 2025, using code 52313.
TOMI's BIT platform, developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP) technology for superior disinfection across various sectors including healthcare, biosafety, pharmaceutical, commercial, and public safety facilities.